Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation
- PMID: 12829610
- DOI: 10.1182/blood-2003-01-0150
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation
Abstract
Antigens implicated in the graft-versus-leukemia (GVL) effect in chronic myeloid leukemia (CML) include WT1, PR1, and BCR-ABL. To detect very low frequencies of these antigen-specific CD8+ T cells, we used quantitative polymerase chain reaction (qPCR) to measure interferon-gamma (IFN-gamma) mRNA production by peptide-pulsed CD8+ T cells from HLA-A*0201+ healthy volunteers and from patients with CML before and after allogeneic stem cell transplantation (SCT). Parallel assays using cytomegalovirus (CMV) pp65 tetramers demonstrated the IFN-gamma copy number to be linearly related to the frequency of tetramer-binding T cells, sensitive to frequencies of 1 responding CD8+ T cell/100 000 CD8+ T cells. Responses to WT1 and PR1 but not BCR-ABL were detected in 10 of 18 healthy donors. Responses to WT1, PR1, or BCR-ABL were observed in 9 of 14 patients with CML before SCT and 5 of 6 after SCT, often to multiple epitopes. Responses were higher in patients with CML compared with healthy donors and highest after SCT. These antigen-specific CD8+ T cells comprised central memory (CD45RO+CD27+CD57-) and effector memory (CD45RO-CD27-CD57+) T cells. In conclusion, leukemia-reactive CD8+ T cells derive from memory T cells and occur at low frequencies in healthy individuals and at higher frequencies in patients with CML. The increased response in patients after SCT suggests a quantitative explanation for the greater effect of allogeneic SCT.
Comment in
-
BCR-ABL-specific T cells can be detected in healthy donors and in chronic myeloid leukemia patients following allogeneic stem cell transplantation.Blood. 2004 Apr 15;103(8):3245. doi: 10.1182/blood-2003-11-4086. Blood. 2004. PMID: 15070713 No abstract available.
Similar articles
-
Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.Blood. 2007 Sep 15;110(6):1924-32. doi: 10.1182/blood-2007-03-076844. Epub 2007 May 15. Blood. 2007. PMID: 17505014 Free PMC article.
-
Graft-versus-leukemia effects of Wilms' tumor 1 protein-specific cytotoxic T lymphocytes in patients with chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation.Chin Med J (Engl). 2010 Apr 5;123(7):912-6. Chin Med J (Engl). 2010. PMID: 20497687 Clinical Trial.
-
The receptor for hyaluronic acid-mediated motility induces specific CD8+ T cell response in healthy donors and patients with chronic myeloid leukemia after allogeneic stem cell transplantation.Int J Oncol. 2007 May;30(5):1119-27. Int J Oncol. 2007. PMID: 17390013
-
Chronic myeloid leukemia as an immunological target.Am J Hematol. 1997 Jan;54(1):61-7. doi: 10.1002/(sici)1096-8652(199701)54:1<61::aid-ajh9>3.0.co;2-2. Am J Hematol. 1997. PMID: 8980262 Review.
-
Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable?Cancer Immunol Immunother. 2009 Sep;58(9):1489-99. doi: 10.1007/s00262-009-0675-x. Epub 2009 Mar 4. Cancer Immunol Immunother. 2009. PMID: 19259670 Free PMC article. Review.
Cited by
-
T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation.Cancer Immunol Immunother. 2005 Nov;54(11):1043-58. doi: 10.1007/s00262-005-0681-6. Epub 2005 May 11. Cancer Immunol Immunother. 2005. PMID: 15887014 Free PMC article. Review.
-
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.Blood. 2010 Jul 15;116(2):171-9. doi: 10.1182/blood-2009-10-250993. Epub 2010 Apr 16. Blood. 2010. PMID: 20400682 Free PMC article. Clinical Trial.
-
Immunotherapeutic strategies in chronic myeloid leukemia.Curr Hematol Malig Rep. 2007 May;2(2):89-94. doi: 10.1007/s11899-007-0013-3. Curr Hematol Malig Rep. 2007. PMID: 20425356 Review.
-
Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model.Cytotherapy. 2010 Dec;12(8):1056-62. doi: 10.3109/14653249.2010.506506. Epub 2010 Aug 24. Cytotherapy. 2010. PMID: 20735170 Free PMC article.
-
Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation.Clin Cancer Res. 2009 Aug 1;15(15):4944-53. doi: 10.1158/1078-0432.CCR-08-3332. Epub 2009 Jul 14. Clin Cancer Res. 2009. PMID: 19602548 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous